On the eve of a Philadelphia Risperdal trial, Johnson & Johnson and Janssen Pharmaceuticals Inc. agreed to settle a lawsuit alleging a New York boy grew female breasts after...
In the 1950s, the U.S. Food and Drug Administration (FDA) approved a combination of doxylamine and pyridoxine to treat morning sickness in pregnant women. Despite the long history in...
Healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals plan to ring in the new year with results from a seven year long study testing the effectiveness...
The high blood pressure medication Benicar will face generic competition this year, effectively ending its longstanding stranglehold on the market. However, manufacturer Daiichi Sankyo’s trouble with Benicar is merely...
2016 has been a tough year healthcare giant Johnson & Johnson (J&J). The company lost several multimillion dollar baby powder cancer trials, lost a $70 million Risperdal trial, and...
Hundreds of lawsuits are currently pending in a multidistrict litigation against pharmaceutical company Sanofi-Aventis, over its breast cancer chemotherapy drug, Taxotere. Plaintiffs allege the company failed to warn them...
The sixth Risperdal case to go to trial in the Philadelphia mass tort program against manufacturers Janssen Pharmaceuticals and Johnson & Johnson (J&J) has come to an abrupt end...
Pharmaceutical giant Bristol-Myers Squibb agreed to a multistate settlement over unfair and deceptive marketing practices concerning its popular antipsychotic medication Abilify. The company agreed to pay $19.5 million to...
Just weeks after healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals reached a confidential settlement with a Risperdal plaintiff, the companies are going to trial in...
The U.S. Judicial Panel on Multidistrict Litigation granted a coordinated docket for more than 100 lawsuits alleging the diabetes drug Invokana caused significant injuries. Cases are currently being transferred...
